Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Mechanisms and implications of imatinib resistance mutations in BCR-ABL.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Mechanisms and implications of imatinib resistance mutations in BCR-ABL.
Mechanisms and implications of imatinib resistance mutations in BCR-ABL. Curr Opin Hematol. 2004 Jan; 11(1):35-43.
View in:
PubMed
subject areas
Antineoplastic Agents
Benzamides
Drug Resistance, Neoplasm
Fusion Proteins, bcr-abl
Genes, abl
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Piperazines
Point Mutation
Protein-Tyrosine Kinases
Pyrimidines
Signal Transduction
authors with profiles
Valentina Nardi, M.D.
George Quentin Daley, M.D., Ph.D.